Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

N-oleyl-phosphatidylethanolamine/epigallocatechin gallate supplement

A dietary supplement composed of a phosphobioflavonic complex containing two naturally occurring dietary ingredients: the phospholipid N-oleyl-phosphatidylethanolamine (NOPE), which consists of the fatty acid amide oleoyl ethanolamine (OEA) bound to phosphatidylethanolamine (PE), and the flavonol epigallocatechin gallate (EGCG), which is derived from standardized green tea extract, with potential anorexic activity. Upon oral administration of the NOPE/EGCG supplement, NOPE is hydrolyzed into the N-acylethanolamine N-oleyl-ethanolamide (NOE) and phosphatidic acid. NOE inhibits anandamide, thereby preventing the increase in appetite and promotes the activation of several intestinal receptors, which signal the brain center to reduce food intake. EGCG inhibits enzymes that contribute to the degradation of catecholamines, stimulates lipolysis, and promotes weight loss. NOPE and EGCG may work together to provide satiety, improve adherence to a diet, improve performance on impulsivity, and shift fat and sweet preference. This may reduce weight gain and may increase weight loss.
Synonym:N-oleoyl-PE/EGCG
NOPE plus EGCG
NOPE-EGCG
NOPE/EGCG
OEA-PE/EGCG
oleoyl ethanolamine-phosphatidylethanolamine plus EGCG
US brand name:PhosphoLean
Chemical structure:N-oleyl-phosphatidylethanolamine/epigallocatechin gallate
Search NCI's Drug Dictionary